Be sure to check our sister interview main ratings news website

Aptamer Group reports on significant commercial and technical progress in H1 report

Aptamer Group plc (LON: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has announced a trading update for the six months ending 31 December 2024 (H1 25).

Trading update

The Company has made significant advances in its key asset development programmes which are targeted at longer-term and higher-value revenue opportunities as well as its short term fee-for-service work.

Unilever deodorant trials are on track

In partnership with Unilever, Aptamer continues to progress the development of Optimers as a novel active ingredient in deodorants. Trials of the binders with human skin samples were initiated on schedule during Q4 2024. Results from the initial tests at Aptamer showed the binders to be stable indicating suitability for use in personal care products. These tests are being replicated by Unilever and will move to on-person trials shortly.

Read in Full
Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    Aptamer Group

    More articles like this

    Aptamer Group

    Aptamer Group to host webinar and Q&A session for investors

    4th December 2024

    Aptamer Group plc (LON: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has announced that Dr Arron Tolley, Chief Executive Officer and Dr David Bunka, Chief Scientific Officer will be hosting a

    Aptamer Group

    Aptamer Group secures new contracts worth up to £471,000

    6th November 2024

    Aptamer Group plc (LON:APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has provided an update on contracts signed since its financial year ended 30 June 2024. Aptamer has secured new contracts

    Aptamer Group

    Aptamer making significant progress commercially and technically

    22nd October 2024

    Aptamer Group plc (LON:APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has announced its full year results for the twelve months ended 30 June 2024. Highlights ·      New strategic approach launched in August

    Aptamer Group

    Aptamer Group appoints Tim Sykes as a Non-Executive Director

    16th September 2024

    Aptamer Group plc (LON:APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has announced the appointment of Tim Sykes to its Board of Directors as a Non-Executive Director with immediate effect. Tim

    © 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.